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AbstrACt 
Objectives To investigate how young and older people 
perceive the harms associated with legal and illegal drugs.
Design Cross-sectional study: adults aged 18–24 years 
versus 45+ completed an online survey ranking the 
perceived harms associated with 11 drugs on 16 drug-
related harm criteria.
setting Online survey.
Participants 184 participants aged 18–24 years (113 
female: mean age 21: SD 1.3) and 91 participants aged 
45+ (51 female: mean age 60: SD 8.5).
Main outcome measures ‘Perception of drug-related 
harms’: This was measured using a rating scale ranging 
from 1 (no risk of harm) to 4 (high risk of harm). 
Participants were also asked about sources which 
informed their perception on drug-related harms as well as 
their own personal self-reported drug experiences.
results Of the illegal drugs, heroin, methamphetamine 
and cocaine were rated as the most harmful and cannabis 
was rated as the least harmful. Alcohol and tobacco 
were also rated as less harmful. The results showed that 
perceptions of drug-related harms were inconsistent with 
current knowledge from research on drugs. Furthermore, 
perceptions on drug harms were more conservative in 
the 45+ group for a number of illegal drugs and tobacco. 
However, the 45+ age group did not perceive alcohol as 
any more harmful than the younger group.
Conclusions This survey demonstrates that the greatest 
misperception was in relation to alcohol-related harms 
which did not change with age. In order to minimise 
harms, this misperception needs to be addressed through 
education and policies that legislate drug use.
IntrODuCtIOn
Whether legislative or harm reductionist in 
approach, drug (including alcohol) related 
public health policies are focused towards 
reducing drug use and related harms. The 
most comprehensive work quantifying drug 
harms was conducted by Nutt et al1 2 in the 
UK. Using a multicriteria decision analysis 
approach where different harm criteria, 
for example, acute overdose, injury, family 
adversity were weighted relative to their 
importance, alcohol was ranked as the most 
harmful drug overall. Whereas heroin, crack 
cocaine and methamphetamine were rated as 
most harmful to the user, alcohol was rated as 
most harmful to society. Similar results have 
been reported in European studies3 adding 
to the growing clinical and epidemiological 
data that alcohol results in the greatest harm 
and thus economic cost.4 
Drug use normally initiates in adoles-
cence5 with current evidence suggesting 
that use among young people is on the 
increase.6 However, due to the neuroplas-
ticity that occurs during this ontogenetic 
period, the young brain is more susceptible 
to the harmful effects of drugs.6 Adolescent 
use of alcohol increases the risk of alcohol 
dependence7 8 and young people are more 
likely to end up in hospital following acute 
alcohol intoxication and are at most risk 
from alcohol-related road traffic accident 
morbidity and mortality.5 Thus, reducing 
alcohol consumption and related harm in 
young people particularly through the use 
of brief interventions is key to England’s 
and Scotland’s Alcohol Strategy.9–11 Of the 
illicit drugs, cannabis is the most widely used 
by young people7 who perceive this drug as 
less harmless compared with the legal drugs 
alcohol and tobacco.8 9 Explanations offered 
for this are that unlike legal drugs, cannabis 
has potential medical benefits10 11 and is not 
associated with an increased risk of mortality 
from cancer and alcohol-related road traffic 
strengths and limitations of this study
 ► This is the first study to use an appropriate survey 
tool and method to understand age-related pub-
lic health perceptions for legal and illegal drugs 
and how they relate to current research and legal 
frameworks.
 ► Replicability of the present findings in young people 
has been demonstrated.
 ► This study used a convenience sample and not a 
representative sample of participants.
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accidents. However, adolescent cannabis use increases 
vulnerability to its harmful effects7 with early onset of use 
being associated with a greater loss of IQ (average 8 point 
decline) and poorer neuropsychological functioning 
than adult-onset cannabis use.12 Furthermore, it has also 
been proposed by the contested gateway hypothesis that 
early exposure to cannabis may increase the likelihood 
of use of harder illegal drugs (eg, cocaine and heroin), 
with clinical and epidemiological studies evidencing a 
link between early use of cannabis and later exposure to 
other illicit drugs.13 14 A number of vulnerability factors 
have also been associated with early-onset cannabis use 
including depression and anxiety15 and high cannabis use 
is seen in patients with psychosis.16 17 There has also been 
a consistent increase in drug-related deaths in England 
and Wales with highest rates of registered deaths being 
recorded in 2016.18 Although over half of these deaths 
were related to the respiratory depressant effects of 
opiate poisoning, there was also a 16% rise in cocaine-re-
lated deaths from 2015 to 2016. Finally, the picture of 
drug-related harm has been complicated by the introduc-
tion of new psychoactive substances or the so-called ‘legal 
highs’. Although these synthetic agents were made illegal 
under the Misuse of Drugs Act 1971, deaths from these 
substances have also increased from 114 registered deaths 
in 2015 to 123 in 2016.18
The population consumption theory suggests a direct 
link between alcohol consumption and alcohol-related 
harm.4 Older populations, however, are more vulner-
able to the burden of chronic alcohol related disease, 
for example, cirrhosis, fatty liver, pancreatitis, Wernicke’s 
encephalopathy5 with recent findings from a longitudinal 
study suggesting that drinking habits remain stable over 
a 30-year period.19 A report by the Lancet Liver commis-
sion found that alcohol-related mortality in England 
peaked in 2008. However, by reducing the affordability of 
alcohol in the same year via a 2% increase in alcohol tax 
duty, there was a consistent decrease in alcohol-related 
deaths. While Scotland has introduced a fiscal policy of 
minimum unit pricing for alcohol, the tax levy on alcohol 
in England was dropped in 2014, thus making alcohol 
more affordable again. Thus, a potential consequence of 
regional differences in policy could result in decreases in 
alcohol-related mortality in Scotland whereas England 
may again see a rise in alcohol-related death rates.4
In summary, there is robust evidence for the harm and 
public health threat posed by drugs including alcohol 
and how the harms of different drugs may differ by age. 
However, little is known about the public’s perceptions of 
harms associated with these same drugs. Thus, the aim of 
the present study was to investigate how young versus older 
people (18–24 years old vs 45+) understand drug-related 
harms and whether perceptions towards drugs become 
more conservative with age. Given the normative role 
of alcohol within society, the latter question was consid-
ered particularly pertinent to this drug. Furthermore, 
Table 1 Demographics of the study respondents
Study 1 Study 2
16–24 years 16–24 years 45+
Gender
  Male 35 (39.8%) 24 (27.3%) 34 (39.4%)
  Female 53 (60.2%) 60 (68.2%) 51 (59.3%)
  Prefer not to say 4 (4.5%) 1 (1.2%)
Mean age (±SD) 22.65 (1.28) 21.14 (1.33) 60.41 (8.48) t(169)=−42.29, p<0.001
  Male 22.63 (1.21) 21.88 (1.01) 60.62 (9.31)
  Female 22.68 (1.34) 20.79 (1.19) 60.63 (7.88)
Ethnicity χ2=21.68, p<0.001
  White 58 (65.9%) 62 (70.5%) 82 (95.3%)
  Black African/Caribbean 12 (13.6%) 8 (9.1%) 4 (4.7%)
  Asian 10 (11.4%) 9 (10.2%) – 
  Dual heritage 5 (5.7%) 6 (6.8%) – 
  Other 3 (3.4%) 3 (3.4%) –
Education χ2=66.83, p<0.001
  GCSE 2 (2.3%) 10 (11.4%) 53 (61.6%)
  A-level 8 (9.1%) 13 (14.8%) –
  Undergraduate 61 (69.3%) 57 (64.8%) 17 (19.8%)
  Postgraduate 14 (15.9%) 2 (2.3%) 4 (4.7%)
  Other 3 (3.4%) 4 (4.5%) 9 (10.5%)
  Did not say – 2 (2.5%) 1 (1.2%)
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as the largest predictor for alcohol use in adolescence 
is peer drinking,20 data on where young versus older 
people acquired knowledge about drug harms as well as 
their own personal self-reported experiences with drugs 
including alcohol were collected.
MethOD
Materials
To measure perception of ‘drug harms’, the 16 harm 
criteria developed by Nutt et al2 were used. These distin-
guish between harm to the user versus society and are 
grouped into five subheadings of physical, psychological 
and social harm to users and physical and social harm to 
society. Harms of 11 commonly used drugs were assessed: 
heroin, crack cocaine, cocaine, ecstasy, methamphet-
amine, Lysergic acid diethylamide (LSD), amphetamine, 
cannabis and ketamine, alcohol and tobacco. The 16 
harm criteria were carefully explained to the respondents 
and for each criterion, drugs were ranked on a rating scale 
of 1–4; no risk of harm,1 low risk of harm,2 medium risk 
of harm3 and high risk of harm.4 The next section of the 
questionnaire (adapted from21) required respondents to 
rate from a list of possible different sources, the top three 
sources which they believe had most informed their knowl-
edge on drug harms. In addition to the sources of infor-
mation used in the21 study, ‘popular culture, for example, 
books, television (TV), movies, famous people’ was also 
included. The final section of the questionnaire (adapted 
from Morgan et al22) required respondents to self-report 
their most accurate lifetime experience with the drugs 
listed. For the survey questionnaire, see online supple-
mentary information section.
The present research was undertaken in two parts: study 
1 and study 2. In study 1, the harms questionnaire was 
administered to a group of young adult respondents aged 
18–24 years. In study 2, responses on the harms question-
naire were compared between two different age groups: 
18–24 years old versus 45+.
study 1 respondents
Eligible respondents had to be aged between 18 and 24 
years, but no other inclusion criteria were applied and 
demographic information on age, gender, ethnicity and 
level of education was collected. The questionnaire was 
uploaded onto ‘http://www. surveymonkey. com’ and was 
available online from October 2014 to January 2015. It 
was advertised on various social media networks including 
Facebook and via email. A total of 119 responses were 
collected, but there were missing data in 23 of these 
cases, so they were removed from the analysis. This left 96 
respondents who completed the entire questionnaire. On 
inspection of the data, nine of the respondents said that 
they had not heard of at least 1 of the 11 drugs and since 
respondents are not able to rank drugs which they had 
not heard of, their data were removed from the analysis. 
This left a total 88 of respondents. Table 1 represents 
demographic data for these participants. Sixty per cent 
of the sample were females with an average age of 22 
(SD=1.28). Sixty-six per cent of the respondents were of 
white ethnicity with most respondents being university 
students.
study 2 respondents
Eligible respondents had to be adults aged between 
18 and 24 or 45+, but no other inclusion criteria were 
applied and demographic information on age, gender, 
ethnicity and level of education was collected The ques-
tionnaire was distributed electronically via Qualtrics 
Survey Software and for the group aged 18–24 years the 
online survey was available from November 2015 to March 
2016. The 45+ group were recruited via Pureprofile, a 
commercial online survey management system. This-
group of participants were recruited in July 2016 and 
received £3.50 each for their participation.
In total 96 respondents aged 18–24 years and 91 aged 
45+ completed the online questionnaire. Again any 
respondents who said they had not heard of any one of 
the drugs were removed from the analysis leaving a total 
of 88 and 86 respondents in each group, respectively. 
The two samples differed in terms of ethnicity (χ2=21.68, 
p<0.001) with the older sample being less ethnically 
diverse. There were also significant differences in level of 
education (χ2=66.83, p<0.001) with the younger sample 
being university students and the older sample being 
educated to GCSE level (table 1).
Procedure
Respondents were required to read and tick a box to 
acknowledge that they had read the online information 
sheet. Participants were then required to answer six 
informed consent statements including confirmation that 
they were 18 years old or over. The questionnaire took 
approximately 30 min to complete and all responses were 
anonymous.
Patient and public involvement
The current study did not include patient and public 
involvement.
Data analysis
Data were exported to SPSS V.20 for analysis. An overall 
harm rating was obtained for each drug by averaging 
scores for all 16 harm criteria across all participants. 
Spearman’s rank correlations were used to investigate 
relationships between respondent’s knowledge of the 
harms of different drugs in comparison to expert’s harm 
rating2 and to the legal status of a drug according to 
the UK Misuse of Drugs Act.23 The present study used a 
perceived harm ranking scale ranging from 1 to 4. This 
scale was adapted from Morgan et al22 with the absence of 
a 0 score, whereas Nutt et al2 used a scale from 0 to 100. 
Similarly, the Misuse of Drugs Act23 has three classifica-
tions (classes A, B and C) as well as the tacit classification 
of legality which pertains to tobacco and alcohol. This was 
coded on a scale from 1 to 4, with 1 indicating legality and 
4 indicating a class A drug. In study 2, Student’s t-tests 
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were conducted to compare the perception of drug harms 
between the two age groups. The significance threshold 
was set to p<0.05 and values reported are for two-tailed 
hypotheses.
results
study 1
Overall perceived harm rankings
Figure 1 shows in rank order the mean perceived harm 
rating for each drug along with its classification under 
the Misuse of Drugs Act. The class ‘A’ drugs heroin 
(3.76), methamphetamine (3.66), crack cocaine (3.66) 
and cocaine (3.43) were perceived as the most harmful, 
and alcohol was perceived as the third least harmful drug 
(3.13). The class ‘B’ drug cannabis (2.75) was perceived 
as the second least harmful drug, with tobacco (2.41) 
being perceived as least harmful. A Spearman’s rank 
correlation revealed a significant positive relationship 
between the respondents harm ratings of drugs and its 
legal classification (r=0.70, n=11, p=0.01) with higher 
perceived harm ratings given to drugs that were within a 
higher drug class. However, there was no statistical rela-
tionship between the young people’s perceived harm 
ratings against those of Nutt et al’s2 expert panel (r=0.38, 
n=11, pNS; see figure 2).
sources reported to acquire knowledge on drug harms and 
self-reported experiences with drugs in young people
The most influential source of information from which 
18–24 year olds self-reported acquiring knowledge on 
drug harms were ‘Mine and my friends own experiences’ 
(29.2%) and ‘popular culture, for example, books, TV, 
movies, famous people’ (19.8%) (see figure 3). Least 
influential included ‘peer-reviewed articles’ (3.1%) and 
‘government sponsored ad campaigns’ (3.1%).
When asked about their own experiences with the 11 
drugs, respondents were most likely to have used alcohol 
(63.2%), followed by cannabis (45.3%) and tobacco 
(44.2%). 29.5% of respondents described themselves as 
regular users of alcohol, 7.4% as regular tobacco users 
and 5.3% as regular cannabis users (table 2). 24.2% of 
the study respondents reported having tried ecstasy and 
1% of the respondents appeared to describe themselves 
as poly-drug users. The drugs that respondents were least 
likely to have heard of were LSD and ketamine.
study 2
Overall perceived harm ranking
Figure 4 compares perceived harm ratings in the 
18–24 years versus the 45+ group. In general, percep-
tions on drug harms were more conservative in the 
45+group who rated 8/11 drugs as being more harmful 
than the 18–24 years group. There were, however, three 
notable exceptions: Heroin and cocaine were perceived 
as equally harmful by the two age groups (in both cases 
t (172)<1.24, pNS). Alcohol was perceived as the fourth 
least harmful drug in the 18–24 years and perceptions 
towards it as a harmful drug were not more conservative 
Figure 1 Drugs ordered by their overall harm rating in 18–24 years old. Classification under the Misuse of Drugs Act (class A, B 
and legal) is colour coded.
Figure 2 Correlation between the mean harm ratings of 18–
24 years old and those reported by drug experts in Nutt et al.2
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in the 45+ group (t (172)=1.06, pNS). A Spearman’s rank 
correlation revealed a significant positive relationship 
between perceived harm ratings between 18–24 years 
group in study 1 and 2 (r=0.98, n=11, p=0.001) and 
between 18–24 years old and 45+ age group in study 
2 (r=0.94, n=11, p=0.001). Both the 18–24 years and 
45+ ratings correlated positively with legal classifica-
tions of the drugs (18–24 years old: r=0.62, n=11, p<0.05; 
45+: r=0.79, n=11, p<0.01) but not with expert ratings 
(18–24 years old: r=0.49, n=11, pNS; 45+: r=0.32, n=11, 
pNS).
sources reported to acquire knowledge on drug harms and 
self-reported experiences with drugs in young and older 
people
‘Their own and their friends experiences’ was important 
in how 18–24 years group (75.5%) self-reported acquiring 
knowledge on the drug harms whereas the ‘media 
reporting of drugs’ influences the opinions of both 
18–24 years (40.0%) and 45+ group (56.5%). A ‘drugs 
legal classification’ along with the ‘portrayal of drugs in 
popular culture’ were also ranked highly by both age 
groups and the older group also reported valuing ‘the 
opinions of scientific experts’ (54.1%), figure 5. As shown 
in table 3, young people were significantly more likely to 
be regular users of alcohol (x2=9.1, n=174, p=0.01) but 
there were no significant differences in the use of tobacco 
between 18 and 24 years old versus 45+ group (x2=4.9, 
n=172, p=0.78). The 18–24 years group were more likely 
to have used cocaine (x2=10.09, n=174, p=0.01), and were 
also more likely to self-report regular use of cannabis 
(x2=31.46, n=174, p=0.001) and ecstasy (x2=31.96, 
p=0.001).
Figure 3 Sources rated as most influential by 18–24 years old on acquiring knowledge on drug-related harms ordered by 
cumulative influence. TV, television.
Table 2 Self-reported lifetime experiences of drug use in 
18–24 years old
Drug
Have used 
it (%)
Have not 
used it (%)
Regular 
user (%)
Not heard 
of it (%)
Cocaine 13.7 85.3 1.1 0
LSD 0 94.7 0 5.3
Amphetamine 4.2 92.6 0 3.2
Crack cocaine 1.1 97.9 0 1.1
Alcohol 63.2 7.4 29.5 0
Cannabis 45.3 49.5 5.3 0
Heroin 0 97.9 0 2.1
Tobacco 44.2 47.4 7.4 1.1
Ecstasy 24.2 72.6 1.1 2.1
Ketamine 7.4 84.2 0 8.4
Methamphetamine 0 95.8 1.1 3.2
Figure 4 Mean harm ratings of individual drugs for the 
18–24 years old versus the 45+ age group. *P<0.05, **P<0.01, 
***P<0.001.
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DIsCussIOn
Principal findings
Both young and older people perceived heroin, cocaine, 
crack cocaine and methamphetamine as the most 
harmful and cannabis as the least harmful of the illegal 
drugs. In this respect, the perceived harm ratings of both 
age groups correlated with the legal classification of 
drugs. However, young people perceived alcohol as one 
of the drugs associated with less harm. Similarly, in the 
older group, where perceptions of harms for some drugs 
were more conservative, alcohol was not perceived as any 
more harmful than that reported by the 18–24 year olds. 
The fact that the older age group did not see alcohol as 
more harmful is inconsistent with current knowledge, but 
could possibly be understood on the basis that for this 
group, alcohol is their main form of intoxication, source 
of pleasure and recreation. The drugs both younger and 
older participants most commonly claimed to be ‘regular 
Figure 5 Comparison of the sources rated as most influential in 18–24 years old versus 45+ age group on acquiring knowledge 
on drug related harms.
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users’ of were alcohol and tobacco. Younger participants, 
however, were also more likely to report regular use of 
cannabis and ecstasy. Young people ranked ‘mine and 
my friends own experiences’ as most influential. Govern-
ment sponsored advert campaigns and to a lesser extent 
advice service (eg, Talk to Frank) were rated as less influ-
ential sources on drug-related harms. However, both the 
young and the older group ranked ‘popular culture’ and 
‘media reports’ as influential sources of information on 
drug-related harms.
strengths and limitations
There are several strengths to the present study. This is 
the first study to understand perceptions towards drug 
harms in two samples differing in age. Furthermore, 
perceptions of the harms associated with alcohol are not 
more conservative in an older group that is more likely to 
be assessing the long-term harms of alcohol. This finding 
is in direct contrast to tobacco, which the older partici-
pants did perceive as more harmful. Furthermore, in the 
present paper, the young sample were tested twice in two 
different studies and a strong correlation was reported 
between both studies, suggesting the data are replicable 
and the methodology robust. Other strengths include 
being able to compare our findings with the legal clas-
sification of a drug and against those of experts within 
the field. Limitations include the use of two different 
methods to recruit participants to the second study 
which investigated the effects of age on perceived drug 
harm rankings. The young sample was recruited via 
social media but it was felt the older age group were less 
likely to use social media, and this guided the decision to 
recruit them through a different channel, using an online 
agency which involved a financial incentive. The present 
study also used a cross-sectional study design which could 
mean that the finding that alcohol was not perceived as 
more harmful in the older group is due to cohort differ-
ences. However, that tobacco was perceived as more 
harmful in the older group would not support such an 
explanation. It is clear, however, that some of the differ-
ences between groups may be mediated by factors other 
than age. Our demographic data show a narrow range of 
ethnicities and a broader range of educations. We were 
not able to fully explore the effects of these factors as we 
had limited data in many of the categories (eg, older age 
group had 95% white participants). A further limitation 
is that the two samples were recruited through conve-
nience sampling and are thus not representative of the 
general population and the results may thus be affected 
by sampling bias. Therefore, future research should aim 
to confirm the present findings in representative samples. 
Furthermore, most of the young people recruited to our 
study were university students who were more likely to 
be well educated and they were more ethnically diverse 
compared with the predominately white population in 
the older age group. Indeed the ethnic diversity and the 
inclusion of religious groups where alcohol is prohibited 
would explain the result that 6.1%–7.4% of the young 
population reported no direct experience with alcohol. 
This study used the Nutt matrix of harm2 and some have 
suggested that there are limitations to this approach since 
a drugs harms cannot be reduced to a single score. This 
is because the concept of harm is based on a multitude 
of factors including the pharmacology of a drug, how, in 
the case of poly-drug use; it interacts with other drugs, 
the user’s own behaviour, environmental factors and poli-
cies that legislate drug use. Furthermore, even the most 
objective harm criteria can be subject to some degree of 
social construction, for example, cases when drug-related 
mortality is attributed as the cause of death.24 However, 
Nutt’s work is still the most comprehensive model for 
quantifying the harms associated with different drugs 
and thus considered a good starting platform for under-
standing people’s perception of harms associated with 
different drugs compared with the scientific evidence. As 
the use of new psychoactive substances or the so-called 
legal highs within young people in the UK is on the rise,25 
Table 3 Self-reported lifetime experiences of drug use in 18–24 years old versus 45+ age group
Drug
Regular user (%) Have used it (%) No direct experience (%) Not heard of it (%)
18–24 45+ 18–24 45+ 18–24 45+ 18–24 45+
Cocaine 1 0 23.5 7.5 75.5 92.5 0 0
LSD 0 0 9.2 5.4 83.7 94.6 7.1 0
Amphetamine 0 0 9.2 12.9 87.8 87.1 3.1 0
Crack 0 0 2 0 96.9 100 1 0
Alcohol 51 39.8 42.9 47.3 6.1 12.9 0 0
Cannabis 13.4 1.1 51 29.0 35.7 69.9 0 0
Heroin 0 0 0 1.1 100 98.9 0 0
Tobacco 14.6 12.9 51 49.5 33.3 37.6 1.0 0
Ecstasy 8.2 0 27.6 3.3 62.2 95.7 2.0 1.1
Ketamine 0 0 10.2 1.1 84.7 90.3 5.1 8.6
Methamphetamine 0 0 2.0 2.2 92.9 95.7 5.1 2.2
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the inclusion of these drugs would have helped to estab-
lish a more complete understanding of young people’s 
perceptions of the harms of drugs and how this interacts 
with sociocultural factors. This is considered pertinent 
as the use of synthetic cannabinoid receptor agonists, 
for example, spice has shifted from affluent student 
groups exploring legal highs as a form of recreation to 
more vulnerable young people including the poor, unem-
ployed and young adults in prison. While this group 
perceive legal highs as dangerous and dirty drugs, use in 
these vulnerable populations is driven by cheap price and 
availability.26 Finally, we have not focused on some of the 
benefits that are associated with recreational drug use nor 
on the reasons why drugs are used recreationally.
Comparisons with other studies
Both young and older people perceived heroin, cocaine, 
crack cocaine and methamphetamine as the most 
harmful drugs. These findings paralleled the classifica-
tion of these drugs under the Misuse of Drugs Act 197123 
and research findings reported by the scientific commu-
nity on drug harms.2 Although the legal classification of 
cannabis was upgraded from class ‘C’ to ‘B’ in 2009, our 
study sample perceived it as the least harmful of the illegal 
drugs. Furthermore, although alcohol is rated as the most 
harmful drug by the scientific community,2 3 specifically 
due to the damage it causes to the users physical health, 
for example, cirrhosis, fatty liver, cardiomyopathy, and 
its direct and indirect economic costs (eg, healthcare, 
prison, social services, insurance, crime, absenteeism and 
loss of productivity) an accurate perception of the harms 
of alcohol in relation to other drugs was not evident in 
the current study.
In contrast to the findings with alcohol, tobacco was 
perceived as more harmful in the older group and consis-
tent with this, many of the harmful effects of this drug 
are seen much later in life.27 It is likely that the results 
with tobacco are explained by the smoking ban which 
was introduced in England 10 years ago (1 July 2007). 
This ban imposed restrictions on tobacco advertising and 
smoking in public places, for example,workplaces, which 
led to reduced opportunity to smoke and the creation 
of social norms around smoking being unacceptable.28 
There is also evidence that the smoking ban has reduced 
prevalence rates and the progression of experimental to 
habitual smoking in young people29 and also resulted in 
more quit attempts in young people.30
The findings that the young respondents ranked their 
own experiences and their own friends experiences in 
informing their knowledge on drug harms is consistent 
with similar findings in drug users.21 This finding is also 
consistent with literature that adolescence is defined by 
a period in which peer influence has the greatest effect 
on initiation of substance use.31 Also ranked highly 
by both younger and older respondents was the influ-
ence of popular culture, that is, books, TV, movies and 
famous people’ on informing on drug-related harms. 
The integral nature of drugs as cultural commodities is 
evidenced through the detailed and insightful history 
of drug messages through film, music and advertising. 
In fact, imagery normally associated with illegal drugs, 
that is, dance culture has been used by the drinks 
industry to promote alcohol to young people with music 
being the most influential form of popular culture for 
this group.32
COnClusIOns AnD POlICy IMPlICAtIOns
In summary, the results from the present study suggest 
that perceptions of drug harms in the study sample chal-
lenge what is currently known from scientific research on 
legal drugs.1 2 21 Thus, despite study participants under-
standing the harms associated with illegal drugs, for the 
most part they were less well informed of the harms of 
legal drugs especially alcohol. The misperception of alco-
hol-related harms among the young and older partic-
ipants is concerning given that it is the most regularly 
used drug and thus carries the highest public health 
risk. The present research suggests that although focus 
on drug-related harms in young people is essential, the 
importance of population-level strategies should not be 
underestimated. A recent review established that inter-
ventions found to be most effective in reducing alcohol 
and tobacco intake in young people were taxation, public 
consumption bans, advertising restrictions and minimum 
legal age limits.28 Given the pervasive and normative 
nature of alcohol within society, a huge cultural and 
political shift is required in order for there to be a more 
informed perception of alcohol-related harm. Indeed 
emphasis should be placed on consistency in messages 
from different sources, that is, the legal system, the media 
and popular culture and the alcohol industry.
Since many recreational drugs, especially in young 
people, are not used in isolation, educational strategies 
to reduce drug-related harms could focus on the poten-
tially dangerous pharmacologically synergetic effects 
some drugs have when taken with alcohol. For example, 
severe impairments of driving under the influence of 
cannabis and alcohol33; concomitant use of alcohol and 
cocaine leads to the toxic compound cocaethylene34; the 
suppression of the respiratory system when alcohol and 
benzodiazepines are taken together and findings that a 
combination of alcohol with magic mushrooms can be 
fatal.35 In young people, it is also necessary to increase 
awareness of the pharmacologically lethal effects of high 
doses of alcohol, that is, suppression of the respiratory 
system and death.
In summary, there is a growing need for a better 
understanding of what constitutes optimal public health 
policy to approach the growing health issue of drug use 
and related harms.6 Our findings suggest that younger 
and older people have poor perceptions of drug-related 
harms which while consistent with current UK policy 
are inconsistent with current knowledge. Our findings 
are consistent with the 2018 Global Drug Survey results 
which found that the biggest gap in knowledge was in 
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alcohol-related harm.36 As this is the most widely used 
drug and an inherent part of society, this latter concept 
has to be intrinsically weaved into all approaches and 
policies that aim to be effective in reducing drug-re-
lated harms.
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